Abstract
Mononuclear phagocytes are myeloid-derived effector cells of the innate immune system and comprise peripheral blood monocytes, dendritic cells, tissue macrophages and retinal and brain microglia. Mononuclear phagocytes have been previously implicated in the pathology of age-related macular degeneration (AMD), but it remains unclear, whether recruitment of mononuclear cells from the periphery to the choroid and retina as well as local microglia activation is secondary or primary events in AMD pathogenesis. The identification of functional polymorphisms in the chemokine receptor CX3CR1 with increased risk to develop AMD highlights the importance of chemokine signalling in AMD and supports the hypothesis that aberrant chemokine signalling might play a more primary role than so far anticipated. We here review the evidence for an involvement of myeloid cells in the pathology of AMD and discuss how two major chemotactic cytokine pathways, CCL2–CCR2 and CX3CL1–CX3CR1, control recruitment of systemic monocyte subsets to the retina, how they regulate local activation of macrophages/microglia in the eye and how defects in these signalling pathways might contribute to AMD pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambati J, Anand A, Fernandez S et al (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9:1390–1397
Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP (1995) Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 15:183–191
Boring L, Gosling J, Chensue SW et al (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552–2561
Cardona AE, Pioro EP, Sasse ME et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917–924
Cherepanoff S, McMenamin PG, Gillies MC, Kettle E, Sarks SH (2009) Bruch’s membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol
Colton C (2009) Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain. Journal of Neuroimmune Pharmacology 4:399–418
Combadiere C, Feumi C, Raoul W et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117:2920–2928
Cousins SW, Espinosa-Heidmann DG, Csaky KG (2004) Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol. 2004;122:1013–1018
de Jong PTVM (2006) Age-Related Macular Degeneration. N Engl J Med 355:1474–1485
Geissmann F, Jung S, Littman DR (2003) Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties. Immunity 19:71–82
Gupta N, Brown KE, Milam AH (2003) Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Experimental Eye Research 76:463–471
Jung S, Aliberti J, Graemmel P et al (2000) Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion. Mol Cell Biol 20:4106–4114
Kezic J, McMenamin PG (2010) The Monocyte Chemokine Receptor CX3CR1 Does Not Play a Significant Role in the Pathogenesis of Experimental Autoimmune Uveoretinitis. Invest Ophthalmol Vis Sci 51:5121–5127
Liang KJ, Lee JE, Wang YD et al (2009) Regulation of Dynamic Behavior of Retinal Microglia by CX3CR1 Signaling. Invest Ophthalmol Vis Sci 50:4444–4451
Luhmann UFO, Robbie S, Munro PM et al (2009) The drusen-like phenotype in aging Ccl2 knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50:5934–5943
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 25:677–686
Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14:835–846
Penfold PL, Killingsworth MC, Sarks SH (1985) Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 223:69–76
Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609–618
Tsutsumi C, Sonoda KH, Egashira K et al (2003) The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 74:25–32
Tuo J, Bojanowski CM, Zhou M et al (2007) Murine Ccl2/Cx3cr1 Deficiency Results in Retinal Lesions Mimicking Human Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 48:3827–3836
Tuo J, Smith BC, Bojanowski CM et al (2004) The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J04-1862fje
Xu H, Chen M, Forrester JV (2009) Para-inflammation in the ageing retina. Progress in Retinal and Eye Research 28:348–368
Xu H, Manivannan A, Dawson R et al (2005) Differentiation to the CCR2+ Inflammatory Phenotype In Vivo Is a Constitutive, Time-Limited Property of Blood Monocytes and Is Independent of Local Inflammatory Mediators. J Immunol 175:6915–6923
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Luhmann, U.F.O., Ali, R.R. (2012). Local Vs. Systemic Mononuclear Phagocytes in Age-Related Macular Degeneration and Their Regulation by CCL2–CCR2 and CX3CL1–CX3CR1 Chemokine Signalling. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0631-0_3
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0630-3
Online ISBN: 978-1-4614-0631-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)